First Time Loading...

Guizhou Xinbang Pharmaceutical Co Ltd
SZSE:002390

Watchlist Manager
Guizhou Xinbang Pharmaceutical Co Ltd Logo
Guizhou Xinbang Pharmaceutical Co Ltd
SZSE:002390
Watchlist
Price: 3.96 CNY 1.02% Market Closed
Updated: May 3, 2024
Guizhou Xinbang Pharmaceutical Co Ltd
/
Cash Flow Statement
/
Cash from Financing Activities

Guizhou Xinbang Pharmaceutical Co Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Guizhou Xinbang Pharmaceutical Co Ltd
Cash from Financing Activities Peer Comparison

Comparables:
H
3692
600436
600276
000538
C
300765

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Guizhou Xinbang Pharmaceutical Co Ltd
SZSE:002390
Cash from Financing Activities
-¥876.2m
CAGR 3-Years
-46%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Cash from Financing Activities
-¥818.1m
CAGR 3-Years
8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Cash from Financing Activities
-¥789.1m
CAGR 3-Years
N/A
CAGR 5-Years
-41%
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Cash from Financing Activities
-¥1.8B
CAGR 3-Years
-124%
CAGR 5-Years
N/A
CAGR 10-Years
-36%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Cash from Financing Activities
-¥2.9B
CAGR 3-Years
1%
CAGR 5-Years
-22%
CAGR 10-Years
-25%
C
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
Cash from Financing Activities
¥365.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Guizhou Xinbang Pharmaceutical Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
-876.2m CNY

Based on the financial report for Sep 30, 2023, Guizhou Xinbang Pharmaceutical Co Ltd's Cash from Financing Activities amounts to -876.2m CNY.

What is Guizhou Xinbang Pharmaceutical Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-46%

Over the last year, the Cash from Financing Activities growth was -549%. The average annual Cash from Financing Activities growth rates for Guizhou Xinbang Pharmaceutical Co Ltd have been -46% over the past three years .

ALPHA SPREAD
Join more than 133,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.